Kathleen Rodgers

Summary

Affiliation: University of Southern California
Country: USA

Publications

  1. doi request reprint Regulatory aspects of small molecule drugs for heart regeneration
    Kathleen Rodgers
    Titus Family Department of Clinical Pharmacy and Pharmacoeconomics and Policy, School of Pharmacy, University of Southern California, 1985 Zonal Avenue, Los Angeles, CA 90089, United States Electronic address
    Adv Drug Deliv Rev 96:245-52. 2016
  2. doi request reprint Angiotensin-(1-7) synergizes with colony-stimulating factors in hematopoietic recovery
    Kathleen E Rodgers
    Titus Family Clinical Pharmacy and Pharmaceutical Economics and Policy, School of Pharmacy, University of Southern California, 1985 Zonal Avenue, Room 530, Los Angeles, CA, 90089, USA
    Cancer Chemother Pharmacol 72:1235-45. 2013
  3. pmc Angiotensin-(1-7) administration reduces oxidative stress in diabetic bone marrow
    N M Mordwinkin
    University of Southern California, School of Pharmacy, Keck School of Medicine, 1321 North Mission Road, Los Angeles, California 90033, USA
    Endocrinology 153:2189-97. 2012
  4. pmc Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7)
    Kathleen Rodgers
    University of Southern California, School of Pharmacy, Los Angeles, CA 90815, USA
    Expert Opin Investig Drugs 20:1575-81. 2011
  5. pmc Design of a MCoTI-Based Cyclotide with Angiotensin (1-7)-Like Activity
    Teshome Aboye
    Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089 9121, USA
    Molecules 21:152. 2016
  6. ncbi request reprint Effect of angiotensin II and angiotensin(1-7) on hematopoietic recovery after intravenous chemotherapy
    Kathleen Rodgers
    University of Southern California, Keck School of Medicine, 1321 N Mission Road, Los Angeles, CA 90033, USA
    Cancer Chemother Pharmacol 51:97-106. 2003

Collaborators

  • Laura Bolton
  • Teshome Aboye
  • N M Mordwinkin
  • Subhabrata Majumder
  • Christopher J Meeks
  • Alexander Shekhtman
  • Julio A Camarero
  • S S Jadhav
  • G S diZerega
  • N Roda
  • T Espinoza
  • S G Louie
  • C J Meeks

Detail Information

Publications7

  1. doi request reprint Regulatory aspects of small molecule drugs for heart regeneration
    Kathleen Rodgers
    Titus Family Department of Clinical Pharmacy and Pharmacoeconomics and Policy, School of Pharmacy, University of Southern California, 1985 Zonal Avenue, Los Angeles, CA 90089, United States Electronic address
    Adv Drug Deliv Rev 96:245-52. 2016
    ..This review will focus on regulatory aspects as well as preclinical hurdles of development of new treatments for heart regeneration. ..
  2. doi request reprint Angiotensin-(1-7) synergizes with colony-stimulating factors in hematopoietic recovery
    Kathleen E Rodgers
    Titus Family Clinical Pharmacy and Pharmaceutical Economics and Policy, School of Pharmacy, University of Southern California, 1985 Zonal Avenue, Room 530, Los Angeles, CA, 90089, USA
    Cancer Chemother Pharmacol 72:1235-45. 2013
    ..We evaluated the combination of A(1-7) with colony-stimulating factors, Neupogen and Epogen, on bone marrow progenitors and the recovery of circulating formed elements following chemotherapy...
  3. pmc Angiotensin-(1-7) administration reduces oxidative stress in diabetic bone marrow
    N M Mordwinkin
    University of Southern California, School of Pharmacy, Keck School of Medicine, 1321 North Mission Road, Los Angeles, California 90033, USA
    Endocrinology 153:2189-97. 2012
    ..05). Our findings demonstrate that Ang-(1-7) administration decreases diabetes-induced oxidative stress in the bone marrow and modifies pathways involved in eNOS dysfunction...
  4. pmc Accelerated healing of diabetic wounds by NorLeu(3)-angiotensin (1-7)
    Kathleen Rodgers
    University of Southern California, School of Pharmacy, Los Angeles, CA 90815, USA
    Expert Opin Investig Drugs 20:1575-81. 2011
    ..The resultant ulcers contribute to increased risk of morbidity, including osteomyelitis and amputations, and increased burden to the healthcare system...
  5. pmc Design of a MCoTI-Based Cyclotide with Angiotensin (1-7)-Like Activity
    Teshome Aboye
    Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, Los Angeles, CA 90089 9121, USA
    Molecules 21:152. 2016
    ..This cyclotide also showed high stability in human serum thereby providing a promising lead compound for the design of a novel type of peptide-based in the treatment of cancer and myocardial infarction. ..
  6. ncbi request reprint Effect of angiotensin II and angiotensin(1-7) on hematopoietic recovery after intravenous chemotherapy
    Kathleen Rodgers
    University of Southern California, Keck School of Medicine, 1321 N Mission Road, Los Angeles, CA 90033, USA
    Cancer Chemother Pharmacol 51:97-106. 2003
    ..In view of these findings, the effect of angiotensin peptides on recovery after chemotherapy was assessed...